Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 1;15(1):65.
doi: 10.1186/s13098-023-01042-9.

The impact of insulin resistance on the association between metabolic syndrome and lung function: the Kangbuk Samsung Health Study

Affiliations

The impact of insulin resistance on the association between metabolic syndrome and lung function: the Kangbuk Samsung Health Study

Jonghoo Lee et al. Diabetol Metab Syndr. .

Abstract

Background/objective: Metabolic syndrome (MS) is related to lung dysfunction. However, its impact according to insulin resistance (IR) remains unknown. Therefore, we evaluated whether the relation of MS with lung dysfunction differs by IR.

Subject/methods: This cross-sectional study included 114,143 Korean adults (mean age, 39.6 years) with health examinations who were divided into three groups: metabolically healthy (MH), MS without IR, and MS with IR. MS was defined as presence of any MS component, including IR estimated by HOMA-IR ≥ 2.5. Adjusted odds ratios (aORs) and 95% confidence intervals (CIs) for lung dysfunction were obtained in MS, MS without IR, and MS with IR groups compared with the MH (reference) group.

Results: The prevalence of MS was 50.7%. The percent predicted forced expiratory volume in 1 s (FEV1%) and forced vital capacity (FVC%) showed statistically significant differences between MS with IR and MH and between MS with IR and MS without IR (all P < 0.001). However, those measures did not vary between MH and MS without IR (P = 1.000 and P = 0.711, respectively). Compared to MH, MS was not at risk for FEV1% < 80% (1.103 (0.993-1.224), P = 0.067) or FVC% < 80% (1.011 (0.901-1.136), P = 0.849). However, MS with IR was clearly associated with FEV1% < 80% (1.374 (1.205-1.566) and FVC% < 80% (1.428 (1.237-1.647) (all p < 0.001), though there was no evident association for MS without IR (FEV1%: 1.078 (0.975-1.192, P = 0.142) and FVC%: 1.000 (0.896-1.116, p = 0.998)).

Conclusion: The association of MS with lung function can be affected by IR. However, longitudinal follow-up studies are required to validate our findings.

Keywords: Insulin resistance; Lung function; Metabolic syndrome; Spirometry.

PubMed Disclaimer

Conflict of interest statement

The authors have no competing interests to declare.

Figures

Fig. 1
Fig. 1
Flow diagram of study participants BA = bronchial asthma; COPD = chronic obstructive pulmonary disease; HBsAg = hepatitis B virus surface antigen; HCV-Ab = hepatitis C virus antibody

Similar articles

Cited by

References

    1. Sepulveda-Loyola W, Carnicero JA, Alvarez-Bustos A, Probst VS, Garcia-Garcia FJ, Rodriguez-Manas L. Pulmonary function is associated with frailty, hospitalization and mortality in older people: 5-year follow-up. Heart Lung. 2023;59:88–94. doi: 10.1016/j.hrtlng.2023.01.020. - DOI - PubMed
    1. Higbee DH, Granell R, Davey Smith G, Dodd JW. Prevalence, risk factors, and clinical implications of preserved ratio impaired spirometry: a UK Biobank cohort analysis. Lancet Respir Med. 2022;10(2):149–57. doi: 10.1016/S2213-2600(21)00369-6. - DOI - PubMed
    1. Ramalho SHR, Shah AM. Lung function and cardiovascular disease: a link. Trends Cardiovasc Med. 2021;31(2):93–8. doi: 10.1016/j.tcm.2019.12.009. - DOI - PMC - PubMed
    1. Colak Y, Afzal S, Nordestgaard BG, Lange P, Vestbo J. Importance of early COPD in young adults for development of clinical COPD: findings from the Copenhagen General Population Study. Am J Respir Crit Care Med. 2021;203(10):1245–56. doi: 10.1164/rccm.202003-0532OC. - DOI - PMC - PubMed
    1. Baffi CW, Wood L, Winnica D, Strollo PJ, Jr, Gladwin MT, Que LG, et al. Metabolic syndrome and the lung. Chest. 2016;149(6):1525–34. doi: 10.1016/j.chest.2015.12.034. - DOI - PMC - PubMed

LinkOut - more resources